# Weight Regain After Stopping Tirzepatide, Semaglutide or Liraglutide | Buy This GLP

How much weight returned after stopping tirzepatide, semaglutide or liraglutide? See the pooled estimates and what randomized withdrawal evidence adds.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/the-drug-that-works-best-costs-the-most-to-stop
Updated: 2026-11-15
Published: 2026-09-17

[← Research](https://buythisglp.com/research)

Evidence

# Weight Regain After Stopping Tirzepatide, Semaglutide or Liraglutide

A 17-study review estimated weight regain after stopping treatment. The pooled figures cover different study populations and follow-up periods.

Editorial profile: [Carla Medina](https://buythisglp.com/authors/carla-medina)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20264 min readUpdated November 2026

Weight regained after stopping, pooled · liraglutide 3.0 mg · 4.83% · semaglutide 2.4 mg · 7.19% · tirzepatide · 13.04% · Separate study groups with different follow-up.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   A review of 17 studies estimated 7.20% average weight regain after stopping weight-management medication.
-   Regain estimates differed across drugs, study populations and follow-up periods.
-   The pooled figures cannot rank drugs for an individual patient’s risk of regain.

A review pooled weight measurements from the end of obesity treatment to a later follow-up [\[1\]](https://buythisglp.com/research/the-drug-that-works-best-costs-the-most-to-stop#ref-1). Individual trials in our guide to [weight regain after stopping a GLP-1](https://buythisglp.com/research/how-much-weight-do-you-regain-after-stopping) provide a clearer view of specific follow-up periods. The studies in this pooled analysis differed considerably.

## What the pooled figures mean

The review included 17 studies and 3,793 participants in groups that stopped treatment. The pooled estimate of weight regain was 7.20%, with a 95% confidence interval of 5.93% to 8.48% [\[1\]](https://buythisglp.com/research/the-drug-that-works-best-costs-the-most-to-stop#ref-1). The percentage describes the change in weight after treatment ended. It does not describe the share of previously lost weight that returned.

Separate estimates were 4.83% for liraglutide, 7.19% for semaglutide and 13.04% for tirzepatide. The groups differed in starting weight, earlier weight loss and time since treatment stopped. Eleven studies were retrospective and only three were randomized. The drug-specific figures are indirect comparisons.

## What a randomized withdrawal trial can show

SURMOUNT-4 randomized adults who completed an initial tirzepatide treatment period to continue or switch to placebo [\[2\]](https://buythisglp.com/research/the-drug-that-works-best-costs-the-most-to-stop#ref-2). Research on [whether a lower dose can maintain weight loss](https://buythisglp.com/research/can-you-lower-your-glp1-dose-to-maintain) studies a different decision from stopping. Over the next 52 weeks, the placebo group gained 14.0% from its week 36 weight. The group that continued tirzepatide lost another 5.5%. Those figures apply to adults who reached the randomized phase.

## Frequently asked

How much weight came back on average?

The pooled estimate was 7.20% of body weight after treatment stopped, with a 95% confidence interval of 5.93% to 8.48%.

Does tirzepatide cause more weight regain?

The pooled tirzepatide estimate was numerically higher. Separate study groups and follow-up periods prevent a reliable direct comparison.

What did a randomized withdrawal trial show?

Participants switched from tirzepatide to placebo gained 14.0% over the next year on average. Those continuing tirzepatide lost another 5.5%.

## Sources

1.  \[1\] Patel H, Babli SA, Shah S, et al. (2026). Post-cessation Weight Regain After Weight Management Medications: A Systematic Review and Meta-Analysis Cureus. [PMID 42534203](https://pmc.ncbi.nlm.nih.gov/articles/PMC13419888/)
2.  \[2\] Aronne LJ, Sattar N, Horn DB, et al. (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial JAMA. [PMID 38078870](https://pubmed.ncbi.nlm.nih.gov/38078870/)

## Where to get it

### The cheapest GLP-1

Every seller that publishes a price, ordered lowest first on the standing month-to-month rate, plus the question to ask before you pay any of them.

[See the board →](https://buythisglp.com/best/cheapest-glp1)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
